Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novo Nordisk expands social media efforts with new Twitter account

Danish pharma company's US business joins the social network

Novo Nordisk US Twitter account

Novo Nordisk has expanded its social media efforts, launching a new Twitter account for its US business.

It joins the Danish pharma company's existing accounts on the social network, which focus on corporate sustainability, graduate recruitment, and government affairs and public policy.

Its most note-worthy US social media initiative to date has been its sponsorship of Race with Insulin, which is pharma's first – and, so far, only – branded Twitter account.

Run by Indy car driver, and Novo-paid spokesman, Charlie Kimball, who has type I diabetes, the Twitter account's background currently features branding for the NovoLog Flexpen.

Novo's new Twitter account will be run by its US media relations and corporate communications director Ken Inchausti and focus on “news and views on diabetes and chronic disease for US audiences”.

• Links to Novo's new Twitter account and its existing social media initiatives can be found in the Digital Handbook's pharma social media directory

30th April 2012

From: Marketing

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics